The Great Carve-Out Race: Why 57% of Corporates Are Pursuing Portfolio Rationalization in 2026

A KPMG survey released earlier this spring captured something the deal tape has been telling us for months. Roughly 57 percent of corporate dealmakers and 71 percent of private equity firms say they are open to or actively pursuing portfolio rationalization in 2026. Carve-outs, the sale of a division or business unit out of a larger parent, are no longer a fallback option. They are a deliberate strategy that is now reshaping the M&A market across industrials, consumer, healthcare, and technology.

What's Driving the Surge

For most of the post-pandemic period, large corporates held onto sprawling portfolios. Cheap capital and steady earnings made empire-building feel inexpensive, and divestitures often looked like an admission that something had gone wrong. That equation has reversed. Persistently higher interest rates have lifted the cost of holding marginal businesses. Activist investors and quiet engagement from large index holders have raised the price of strategic ambiguity. And boards, watching pure-play peers trade at premiums to their conglomerate cousins, have started asking the hard question: which units inside our walls would actually trade higher on their own?

Add to that the impact of artificial intelligence on operating models, geopolitical fragmentation that has changed the calculus for global supply chains, and a private capital base flush with dry powder, and the conditions for carve-outs look as supportive as they have in a decade. The KPMG data also shows that 51 percent of corporates expect carve-out activity to rise moderately to significantly over the next 12 to 24 months, with 11 percent projecting a significant increase. That is a meaningful directional signal.

Who Is Buying

Two buyer pools are absorbing most of this supply. Private equity sponsors, particularly those with operational improvement playbooks, have been the most aggressive. Sponsors see a corporate parent that has under-invested in a non-core unit, and they price in the value they believe a focused management team and dedicated capital can unlock. Sun Pharma's recent $11.75 billion bid for Organon, and Apollo's $2.1 billion carve-out of Forvia's auto interiors business, both announced in late April, sit in this lineage of strategic-to-sponsor handoffs.

The second pool is strategic buyers running their own simplification playbook. A focused industrial company will pay a premium to bolt on a complementary division if it strengthens a single business line, even when the parent might struggle to monetize the same asset. The math here is favorable for sellers: when both sponsors and strategics are circling, competitive tension extends past auction stage into best-and-final.

The Hidden Costs Sellers Underestimate

Carve-outs look simple on a one-page deal summary and rarely are. The headline EBITDA of a divested business often relies on shared services, group purchasing, and corporate overhead that the buyer will not inherit on day one. A standalone cost build, sometimes called a "go-it-alone" budget, can quickly take 100 to 300 basis points off the unit's run-rate margin if it is not negotiated carefully through a transition services agreement.

Operational disentanglement is the single largest execution risk. KPMG's survey put the figure at 52 percent of corporates citing this as the toughest challenge, followed by valuation complexity at 43 percent and IT and data separation at 40 percent. Each of those becomes a bargaining chip in the deal. Buyers will price in transition services costs, IT migration risk, and key employee retention. Sellers who underestimate these issues either lose value at the LOI stage or, worse, see deals collapse during diligence.

How the Buyer Looks at the Asset

A sponsor evaluating a carve-out is solving for three questions. First, can a clean management team, with dedicated capital, materially improve operating performance within five years? Second, what does the standalone cost structure look like once it is no longer subsidized by corporate? Third, what is the integration path or platform play that justifies a multiple expansion at exit?

Sellers who understand this lens prepare differently. They invest in a sell-side quality of earnings analysis that pre-emptively addresses the standalone P&L question. They line up a transition services framework with realistic costs and durations before the data room opens. They identify and incentivize the management team that will go with the asset. Each of these moves protects price and reduces the friction that turns 8 to 10 month auction processes into 14 to 18 month grinds.

What to Watch Through the Rest of 2026

Three threads are worth tracking. First, whether the volume of corporate divestitures translates into a glut of similar assets in particular sectors, which could compress multiples. Industrials and parts of consumer goods are the most exposed. Second, the ability of private credit to finance these transactions at scale. Direct lending to sponsor-backed carve-outs has been a growth engine for the last two years, and any cooling there will quickly show up in deal economics. Third, the quality of the management teams that come with these assets. A polished management team plus a clean QoE often determines whether a carve-out trades at the high end of its range or at a discount.